XML 24 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2017
Dec. 31, 2016
Current Assets    
Cash and cash equivalents (variable interest entity restricted - 2017: $13; 2016: $18) $ 501 $ 638
Trade receivables - third party and affiliates (net of allowance for doubtful accounts - 2017: $6; 2016: $6; variable interest entity restricted - 2017: $5; 2016: $4) 886 801
Non-trade receivables, net 216 223
Inventories 717 720
Marketable securities, at fair value 31 30
Other assets 38 60
Total current assets 2,389 2,472
Investments in affiliates 874 852
Property, plant and equipment (net of accumulated depreciation - 2017: $2,307; 2016: $2,239; variable interest entity restricted - 2017: $724; 2016: $734) 3,571 3,577
Deferred income taxes 154 159
Other assets (variable interest entity restricted - 2017: $8; 2016: $9) 308 307
Goodwill 800 796
Intangible assets (net of accumulated amortization - 2017: $531; 2016: $524; variable interest entity restricted - 2017: $26; 2016: $26) 192 194
Total assets 8,288 8,357
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 107 118
Trade payables - third party and affiliates 615 625
Other liabilities 262 322
Income taxes payable 31 12
Total current liabilities 1,015 1,077
Long-term debt, net of unamortized deferred financing costs 2,851 2,890
Deferred income taxes 140 130
Uncertain tax positions 138 131
Benefit obligations 866 893
Other liabilities 237 215
Commitments and Contingencies
Stockholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2017 and 2016: 0 issued and outstanding) 0 0
Treasury stock, at cost (2017: 28,412,876 shares; 2016: 26,950,910 shares) (1,662) (1,531)
Additional paid-in capital 149 157
Retained earnings 4,451 4,320
Accumulated other comprehensive income (loss), net (327) (358)
Total Celanese Corporation stockholders' equity 2,611 2,588
Noncontrolling interests 430 433
Total equity 3,041 3,021
Total liabilities and equity 8,288 8,357
Series A common stock, $0.0001 par value, 400,000,000 shares authorized (2017: 167,965,429 issued and 139,552,553 outstanding; 2016: 167,611,357 issued and 140,660,447 outstanding)    
Stockholders' Equity    
Common stock 0 0
Series B common stock, $0.0001 par value, 100,000,000 shares authorized (2017 and 2016: 0 issued and outstanding)    
Stockholders' Equity    
Common stock $ 0 $ 0